Amazon Driver at Gunpoint: Safety Uproar & Legal Demandsby Lilu Anderson 14.02.2024An Amazon delivery driver being held at gunpoint highlights the safety concerns for workers and calls for stricter penalties for ...
Navigating AI’s Ethical Pitfalls: Bias Maze Insightsby Lilu Anderson 14.02.2024The article discusses the ethical challenges of artificial intelligence (AI) and the need for fairness and equity in its development. ...
Virtual Reality Therapy: Transforming Palliative Careby Lilu Anderson 14.02.2024A recent clinical trial in Japan reveals that virtual reality therapy can greatly improve the physical and emotional symptoms of ...
Will Mitchell Drives Growth at AFC: What’s Ahead?by Mark Eisenberg 14.02.2024Will Mitchell has been appointed as the new president of Automotive Finance Corporation, signaling growth and innovation in vehicle financing ...
California’s Bold Move: Legislation Against AI Exploitationby Lilu Anderson 14.02.2024California's groundbreaking legislation aims to combat AI-generated child exploitation material, closing a legal gap in child protection laws. The bipartisan ...
Polaris Technologies Commits $100M Boostby Lilu Anderson 14.02.2024Polaris Technologies Inc.'s $100M investment in a data center in Muskogee will boost the local economy and create job opportunities, ...
Hong Kong’s Financial Sector: 2024’s Cautious Start Amid Fearsby Terry Bingman 14.02.2024Hong Kong's financial sector starts 2024 cautiously amid economic concerns. Layoffs, sluggish deal-making, and stock market decline create apprehension. Major ...
Arm’s Record Dive: AI Hype Cools Off?by Mark Eisenberg 14.02.2024Arm Holdings PLC experienced its largest stock decline since going public, as the hype around AI investments cools down. Market ...
SEC Chief: Beware of AI-Washing in Investmentsby Mark Eisenberg 14.02.2024SEC Chair Gary Gensler warns against the practice of "AI-washing" in the investment realm, emphasizing the need for transparency and ...
Merrimack Pharmaceuticals Closure: Impact on Shareholdersby Mark Eisenberg 14.02.2024Merrimack Pharmaceuticals is set to dissolve after receiving a $225 million payment for FDA approval. Shareholders will receive a dividend ...